Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MIRM · as of Jun 8, 2026
Key Statistics
Explore Mirum Pharmaceuticals, Inc. Data
mirm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 100.0%
The MIRM analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $142.55, representing +52.49% upside from the current price of $93.48.
Competitors & Peers
mirm competitorsMIRM
ACAD
ADMA
BLTE
DYN
LGNDStock Performance
Full HistoryAbout Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product cand…
what is mirum pharmaceuticals, inc. · mirm stock overview · mirum pharmaceuticals, inc. company profile · who is mirum pharmaceuticals, inc. ceo · mirm NASDAQ · mirum pharmaceuticals, inc. headquarters · mirum pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Mirum Pharmaceuticals, Inc. (MIRM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 18, 2019. As of the latest trading session, MIRM stock price is $93.48, with a market capitalization of $4.7B. The stock has returned +98.68% over the past 12 months and +18.34% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Mirum Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $142.55. In fiscal year 2025, Mirum Pharmaceuticals, Inc. reported revenue of $521.3M and net income of -$23.4M. For detailed data — including Mirum Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mirum Pharmaceuticals, Inc. (MIRM) stock price is $93.48. The stock is traded on NASDAQ under the ticker symbol MIRM. The 52-week range is $43.50 – $114.99.